FIELD: medicine.SUBSTANCE: group relates to the treatment and/or prevention of cancer, dependent on the natural AHR ligand. To this end, a therapeutically effective amount of an arylhydrocarbon receptor (AHR) inhibitor is administered.EFFECT: possibility of effective treatment or prevention of a brain tumour, the pathogenesis of which is justified by unbalanced production of kynurenin.15 cl, 24 dwg, 4 ex
MEANS AND METHODS FOR CANCER TREATMENT AND/OR PREVENTION DEPENDING ON NATURAL AHR LIGAND